{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:20:10Z","timestamp":1793895610008,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41591-025-03926-x","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:06:09Z","timestamp":1757408769000},"page":"2901-2912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The WHO global landscape of cancer clinical trials"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-9736","authenticated-orcid":false,"given":"Raffaella","family":"Casolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambed","family":"Tatah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Charnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Santero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e8","family":"Ilbawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Laura","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"3926_CR1","doi-asserted-by":"publisher","first-page":"e076962","DOI":"10.1136\/bmj-2023-076962","volume":"384","author":"J Shelton","year":"2024","unstructured":"Shelton, J. et al. 25 year trends in cancer incidence and mortality among adults aged 35\u201369 years in the UK, 1993\u20132018: retrospective secondary analysis. BMJ 384, e076962 (2024).","journal-title":"BMJ"},{"key":"3926_CR2","unstructured":"Howlader, N. et al. SEER Cancer Statistics Review 1975\u20132018 (National Cancer Institute, 2021)."},{"key":"3926_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"3926_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamaoncol.2021.0379","volume":"7","author":"JC Del Paggio","year":"2021","unstructured":"Del Paggio, J. C. et al. Evolution of the randomized clinical trial in the era of precision oncology. JAMA Oncol. 7, 728\u2013734 (2021).","journal-title":"JAMA Oncol."},{"key":"3926_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S1470-2045(23)00319-4","volume":"24","author":"CM Booth","year":"2023","unstructured":"Booth, C. M. et al. Common sense oncology: outcomes that matter. Lancet Oncol. 24, 833\u2013835 (2023).","journal-title":"Lancet Oncol."},{"key":"3926_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41573-023-00723-4","volume":"22","author":"EC Scott","year":"2023","unstructured":"Scott, E. C. et al. Trends in the approval of cancer therapies by the FDA in the twenty-first century. Nat. Rev. Drug Discov. 22, 625\u2013640 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3926_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejca.2021.07.001","volume":"155","author":"JM Boyle","year":"2021","unstructured":"Boyle, J. M. et al. Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: a retrospective cohort study. Eur. J. Cancer 155, 136\u2013144 (2021).","journal-title":"Eur. J. Cancer"},{"key":"3926_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaoncol.2020.7478","volume":"7","author":"JC Wells","year":"2021","unstructured":"Wells, J. C. et al. An analysis of contemporary oncology randomized clinical trials from low\/middle-income vs high-income countries. JAMA Oncol. 7, 379\u2013385 (2021).","journal-title":"JAMA Oncol."},{"key":"3926_CR9","doi-asserted-by":"publisher","first-page":"e2227252","DOI":"10.1001\/jamanetworkopen.2022.27252","volume":"5","author":"F Rubagumya","year":"2022","unstructured":"Rubagumya, F. et al. Participation of lower and upper middle-income countries in clinical trials led by high-income countries. JAMA Netw. Open 5, e2227252 (2022).","journal-title":"JAMA Netw. Open"},{"key":"3926_CR10","unstructured":"WHO. The Thirteenth General Program of Work, 2019\u20132023 https:\/\/www.who.int\/about\/general-programme-of-work\/thirteenth (2019)."},{"key":"3926_CR11","unstructured":"WHO. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013\u20132020 www.who.int\/publications\/i\/item\/978924150623 (2013)."},{"key":"3926_CR12","unstructured":"WHO. Cancer Prevention and Control in the Context of an Integrated Approach https:\/\/iris.who.int\/handle\/10665\/275676 (2017)."},{"key":"3926_CR13","doi-asserted-by":"crossref","unstructured":"Hyder, A. A. et al. Strengthening evidence to inform health systems: opportunities for the WHO and partners to accelerate progress on non-communicable diseases. J Glob. Health 8, e013994 (2023).","DOI":"10.1136\/bmjgh-2023-013994"},{"key":"3926_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(23)02798-8","volume":"403","author":"V Moorthy","year":"2024","unstructured":"Moorthy, V. et al. The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum. Lancet 403, 124\u2013126 (2024).","journal-title":"Lancet"},{"key":"3926_CR15","unstructured":"WHO. International Clinical Trials Registry Platform (ICTRP) www.who.int\/clinical-trials-registry-platform (2005)."},{"key":"3926_CR16","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/jnci\/djab070","volume":"113","author":"D Habr","year":"2021","unstructured":"Habr, D., McRoy, L. & Papadimitrakopoulou, V. A. Age is just a number: considerations for older adults in cancer clinical trials. J. Natl Cancer Inst. 113, 1460\u20131464 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"3926_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11690-9","volume":"24","author":"S Zhao","year":"2024","unstructured":"Zhao, S. et al. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants. BMC Cancer 24, 30 (2024).","journal-title":"BMC Cancer"},{"key":"3926_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4259704","volume":"2017","author":"K Lynch-Kelly","year":"2017","unstructured":"Lynch-Kelly, K., Singer, M. & Williams, N. R. The landscape of randomised controlled trials of therapies in breast cancer in low and middle income countries. Int. J. Breast Cancer 2017, 4259704 (2017).","journal-title":"Int. J. Breast Cancer"},{"key":"3926_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaoncol.2024.1690","volume":"10","author":"WT Swenson","year":"2024","unstructured":"Swenson, W. T., Swenson, A., Westergard, E. & Schroeder, Z. Geographic distribution of clinical trials for advanced-stage cancer. JAMA Oncol. 10, 1132\u20131133 (2024).","journal-title":"JAMA Oncol."},{"key":"3926_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101610","volume":"8","author":"E Charton","year":"2023","unstructured":"Charton, E. et al. Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study. ESMO Open 8, 101610 (2023).","journal-title":"ESMO Open"},{"key":"3926_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100515","volume":"7","author":"G Tini","year":"2022","unstructured":"Tini, G. et al. Quantifying geographical accessibility to cancer clinical trials in different income landscapes. ESMO Open 7, 100515 (2022).","journal-title":"ESMO Open"},{"key":"3926_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","volume":"28","author":"CS Pramesh","year":"2022","unstructured":"Pramesh, C. S. et al. Priorities for cancer research in low- and middle-income countries: a global perspective. Nat. Med. 28, 649\u2013657 (2022).","journal-title":"Nat. Med."},{"key":"3926_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-018-0748-6","volume":"17","author":"C Alemayehu","year":"2018","unstructured":"Alemayehu, C., Mitchell, G. & Nikles, J. Barriers for conducting clinical trials in developing countries\u2014 a systematic review. Int. J. Equity Health 17, 37 (2018).","journal-title":"Int. J. Equity Health"},{"key":"3926_CR24","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1016\/S1470-2045(23)00412-6","volume":"24","author":"C Are","year":"2023","unstructured":"Are, C. et al. Global cancer surgery: pragmatic solutions to improve cancer surgery outcomes worldwide. Lancet Oncol. 24, e472\u2013e518 (2023).","journal-title":"Lancet Oncol."},{"key":"3926_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ijrobp.2018.03.009","volume":"101","author":"A Aggarwal","year":"2018","unstructured":"Aggarwal, A. et al. Radiation therapy research: a global analysis 2001\u20132015. Int. J. Radiat. Oncol. Biol. Phys. 101, 767\u2013778 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"3926_CR26","doi-asserted-by":"publisher","first-page":"e2145511","DOI":"10.1001\/jamanetworkopen.2021.45511","volume":"5","author":"BO Wong","year":"2022","unstructured":"Wong, B. O. et al. Analysis of registered clinical trials in surgical oncology, 2008\u20132020. JAMA Netw. Open 5, e2145511 (2022).","journal-title":"JAMA Netw. Open"},{"key":"3926_CR27","unstructured":"WHO. International Standards for Clinical Trial Registries https:\/\/www.who.int\/publications\/i\/item\/international-standards-for-clinical-trial-registers (2018)."},{"key":"3926_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMsr1601330","volume":"376","author":"DA Zarin","year":"2017","unstructured":"Zarin, D. A., Tse, T., Williams, R. J. & Rajakannan, T. Update on trial registration 11 years after the ICMJE policy was established. N. Engl. J. Med. 376, 383\u2013391 (2017).","journal-title":"N. Engl. J. Med."},{"key":"3926_CR29","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association.","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191\u20132194 (2013).","journal-title":"JAMA"},{"key":"3926_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07869-x","volume":"25","author":"T Patrick-Brown","year":"2024","unstructured":"Patrick-Brown, T. et al. Experiences and challenges with the new European Clinical Trials Regulation. Trials 25, 3 (2024).","journal-title":"Trials"},{"key":"3926_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2018.08.024","volume":"104","author":"M Begum","year":"2018","unstructured":"Begum, M. et al. Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: implications for future national cancer control planning. Eur. J. Cancer 104, 127\u2013136 (2018).","journal-title":"Eur. J. Cancer"},{"key":"3926_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/d41573-020-00099-9","volume":"19","author":"JX Yu","year":"2020","unstructured":"Yu, J. X., Upadhaya, S., Tatake, R., Barkalow, F. & Hubbard-Lucey, V. M. Cancer cell therapies: the clinical trial landscape. Nat. Rev. Drug Discov. 19, 583\u2013584 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3926_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/annonc\/mdx755","volume":"29","author":"J Tang","year":"2018","unstructured":"Tang, J., Shalabi, A. & Hubbard-Lucey, V. M. Comprehensive analysis of the clinical immuno-oncology landscape. Ann. Oncol. 29, 84\u201391 (2018).","journal-title":"Ann. Oncol."},{"key":"3926_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","volume":"28","author":"SJ Bagley","year":"2022","unstructured":"Bagley, S. J. et al. Glioblastoma clinical trials: current landscape and opportunities for improvement. Clin. Cancer Res. 28, 594\u2013602 (2022).","journal-title":"Clin. Cancer Res."},{"key":"3926_CR35","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1016\/S2214-109X(25)00012-9","volume":"13","author":"V Moorthy","year":"2025","unstructured":"Moorthy, V. et al. Improving the clinical trial environment and infrastructure: moving from global resolution to action. Lancet Glob. Health 13, e608\u2013e610 (2025).","journal-title":"Lancet Glob. Health"},{"key":"3926_CR36","unstructured":"WHO. Ministerial Summit on Health Research https:\/\/iris.who.int\/handle\/10665\/20384 (2005)."},{"key":"3926_CR37","unstructured":"World Bank. World Bank Country and Lending Groups https:\/\/go.nature.com\/3JWMNHN (2022)."},{"key":"3926_CR38","unstructured":"IARC. Age-Standardized Rate (World) per 100\u2009000, Incidence and Mortality, Both Sexes, in 2022 https:\/\/go.nature.com\/41ZOHgX (2024)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03926-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03926-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03926-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:10:31Z","timestamp":1788516631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03926-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3926"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03926-x","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}